|
|
Newsletter December 2007
A near 20 percent correction
in four weeks has wiped $700 billion off the Shanghai Stock Exchange,
making global investors nervous about a possible China meltdown.
Considering the 132% run of the Shanghai Composite in 2006 and a
subsequent 125 percent run in 2007 before the current pullback, a bubble
theory has ample room to develop. The question is this. Is there
a bubble and if so how to hedge against that? The short answer is this:
there is no China bubble but we give you tips how to minimize your
exposure to the most risky stocks and sectors. Based on different
calculations, the latest fall had lowered the average price-to-earnings
(P/E) ratio of 300 large-cap companies listed in Shanghai and Shenzhen to
33 times 2007 forecast earnings and 28 times 2008 earnings. This is
somewhat high compared to the DJIA’s 16.7 average P/E. Shanghai, a place
where U.S. investors have no access to and is trading independently from
the world markets, is an expensive place to invest due to large demand for
shares in China yet supply is tight. A long list of large companies are
still waiting to get listed in Shanghai. Among them are the world’s
largest mobile carrier by subscriber base China Mobile (NYSE:CHL) and
China’s offshore oil giant CNOOC Ltd. (NYSE:CEO). The good news is that U.S.
listed Chinese stocks follow more conservative Hong Kong prices and
valuations not Shanghai. As a result, large cap NYSE
listed Chinese ADRs are trading at 22.0 P/E, lower than average P/E for
any other major China stock index. Again, NYSE listed Chinese companies
follow Hong Kong trading characteristics including valuations where
average P/E is still a modest 24.4. NASDAQ listed Chinese ADRs are
trading the most expensive relative to earnings and as such they are the
most vulnerable during turbulent times. Considering that valuation for
NYSE and Hong Kong listed
Chinese companies is not far from the average P/E for the DJIA.
we
don’t think there is a China stock bubble. When you think of the China
stock universe, consider this. How many big global companies have seen
economic growth of 10 percent or more since 2002 like China? At this point
the risk is on the upside instead of the downside. I am of the view that current
pullback is more of a U.S. sub prime related volatility issue than
anything else. If you look up “Strong stomach needed” article within the
August 2007 Newsletter, you find that Chinese stocks are 2½ times more volatile that
their U.S. counterparts. And our findings are well supported by current
market statistics. Since October 2007, the
S&P500 lost just about 10 percent, with the Hang Seng following with a
25 percent drop. This is exactly that 2.5 times volatility that we
predicted. Actually, the iShares FTSE/Xinhua China 25 Index (FXI), the
best proxy for the U.S. listed China stock universe, lost 35 percent
making it an attractive play at this time. Fanning out concerns about a
China meltdown is important but there are some problems with Chinese
stocks that we want you to be aware of. For
one, as we just
pointed out NASDAQ listed Chinese ADRs are expensive relative to earnings.
In a nervous market, you may want to trim your exposure to those
names. For
two, recent IPOs
of Chinese companies on U.S. exchanges are small cap, immature enterprises
with no significant earnings history. It is hard to know who is
legitimate. They all come with sound business plans and portray huge
potential, yet what we have learned over the course of the years is that
potential alone means nothing. Companies have to DELIVER
profits. For
three, earnings
for some of the companies have been partially generated by the rise in
stock values because they have invested in the market. When the market
went up, this paid off well but now that the market pulled back, they will
face earnings growth slow down. One of our favorite stocks, China Life
Insurance (NYSE:LFC) is exposed to this problem. The Company reported
investment related net income of $5.4 billion or around 38 percent of
total revenue for 2007 H1. As a conclusion, we suggest investors avoiding
LFC under current volatile
market conditions. And
finally, some of
the Chinese companies have relatively small float or percentage of
tradable shares. As a result, demand for such shares exceed supply
resulting in artificially high valuation. Petrochina (PTR) is a perfect
example of this phenomenon. CNPC, parent company of Petrochina, still owns
approximately 85 percent of all the shares, leaving only 15 for investors.
No wonder Chinese domestic investors pushed valuations sky high at the IPO
in Shanghai, lifting theoretical market cap above $1 trillion. But again,
this is an artificially inflated number derived from Shanghai and has got
more to do with float than with actual valuation. Looking at the valuation
of Petrochina in the NYSE, the stock is trading at 16.7 P/E not much
higher than Exxon Mobile’s P/E of 12.6. Again, not a China bubble but an
issue that we wanted to touch upon, especially after headlines that
Petrochina became the first company ever to reach $1 trillion in market
cap. Our conclusion is this: Petrochina can be very expensive in Shanghai
and seem like a bubble yet it is trading at a relatively modest valuation
on the NYSE. Accordingly, U.S. investors can ignore the high valuation in
Shanghai. Again, current market turmoil
in China is primarily attributed to U.S. related sub prime mortgage
problems. And just how much the Street weights on Hong Kong’s Hang Seng
Index [HSI] is clearly indicated by the following chart. The chart lays
percentage change in the DJIA and the HSI next to each other. The white
ovals on the top chart represent significant market days for the DJIA.
White markings on the bottom indicate next day open for the Hang Seng, the
reaction to the big DJIA day, relative to previous day close.
As the chart demonstrated, big
market days in the U.S. are always followed by a yawning gap in Hong Kong.
If you had known that U.S. markets have a tremendous impact on Hong Kong
trading, this chart is the proof. Concluding that the current
illness in the China stock universe is a derivative of the weakness in
U.S. equity markets, we think it is a fair assumption that as soon as
markets in the U.S. stabilize, Chinese stocks will soar. These stocks are
driven by strong corporate earnings on the back of China’s overall
economic growth. As long as GDP growth in China remains around 10% a year,
Chinese equities will remain attractive investment options.
To understand the depth of
current pull back of Chinese ADRs, let’s take a look at a snapshot from
the daily “Pre-Market Report”. This chart is a graphical representation of
how Chinese ADRs look from a technical point of view at the moment. Not surprisingly the overall
indicator, first one in the row, is bearish. Stocks are much closer to 52
week lows than to highs with no stocks within the Chinese ADR universe
trading above the 20
day-moving-average (DMA). This is a significant development, a reading
that the correction is universal. Most of the stocks are still trading
above their 200 DMA, an indication that the current pullback is still a
short-term development. As the Up/Down Volume section reveals, current
drop takes place under heavy
volume, an another bearish sign. The only somewhat positive sign is that
the Relative Strength Indicator (RSI) is getting to be oversold, a
position when markets are likely to turn around. Still, the overall picture is
far from rosy and is more painful for the investors who purchased stocks
near the high. To put latest correction into
perspective, let’s take a look at the chart on this page. We used the
iShares FTSE/Xinhua China 25 Index (FXI) to track the overall performance
of the U.S. listed China stock universe. As the chart reveals the current
correction of 23.2 percent is not without precedent. The second biggest
drop just occurred at the beginning of the year after a stellar rally in
late 2006. Still 20 percent plus corrections are not common place and
should be noted that there have been three major corrections in year 2007
alone, more than in any year before combined. What does it tell us? Let’s
put these corrections into perspective first. As the chart demonstrates,
there haven't been so sharp rallies before 2007 either, so dramatic
corrections should not come by surprise either. Also, current sickness in the
U.S. markets is something that cuts right into the heart of the economy:
consumer spending. Since consumer spending is responsible for two thirds
of economic activity, a slight decrease in spending sends a chilling
message to Wall Street. From this respect, the Street is nervous and for a
good reason. Another factor that amplified
such a dramatic contraction of Chinese ADRs is coming from the
disappointment as a result of the delay of the “through train” program.
Under the original proposal, Beijing was to let individuals as well as
institutions and funds to invest in Hong Kong directly. This was believed
to channel significant money flows to Hong Kong from Shanghai where
valuation of Chinese stocks was lower. Based on this assumption Chinese
companies listed in Hong Kong started to rally boldly. Think of the 30
percent share price jump overnight of Aluminum Corp. of China
(2600.HK)(NYSE:ACH) on Aug 27. But as investors learned that
Beijing put the brakes on the program and was effectively terminated, a
correction for Hong Kong and subsequent NYSE listed Chinese stocks was
ensured. From this respect, U.S. related problems could not come at a
worst time. Still, NYSE listed Chinese
ADRs are delivering robust earnings growth and as such a bounce back is
just a matter of time. To access latest Newsletter and other research
content, please register!
China bubble
or
not?






